Potential antitumor agent from the endophytic fungus Pestalotiopsis photiniae induces apoptosis via the mitochondrial pathway in HeLa cells

Chen,Chuan; Hu,Shu-Yuan; Luo,Du-Qiang; Zhu,Si-Yu; Zhou,Chuan-Qi

doi:10.3892/or.2013.2618

Potential antitumor agent from the endophytic fungus Pestalotiopsis photiniae induces apoptosis via the mitochondrial pathway in HeLa cells

Authors:
- Chuan Chen
- Shu-Yuan Hu
- Du-Qiang Luo
- Si-Yu Zhu
- Chuan-Qi Zhou
View Affiliations

Affiliations: College of Life Science, Hebei University, Baoding, Hebei 071002, P.R. China, College of Life Science, Key Laboratory of Medicinal Chemistry and Molecular Diagnosis of the Ministry of Education, Hebei University, Baoding, Hebei 071002, P.R. China
Published online on: July 17, 2013 https://doi.org/10.3892/or.2013.2618
Pages: 1773-1781

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

4-(3',3'-Dimethylallyloxy)-5-methyl-6-methoxyphthalide (DMMP) has previously been isolated from the endophytic fungus Pestalotiopsis photiniae. Although the cytotoxic activities of DMMP have been reported, little is known concerning the molecular mechanism of its cytotoxic effect. In the present study, we investigated the effect of DMMP on the growth of several types of cancer cell lines and investigated the mechanism of its antiproliferative effect. DMMP caused the growth inhibition of human cancer lines HeLa, MCF7 and MDA-MB-231, but had little antiproliferative effect on MRC5 normal lung cells. DMMP also significantly caused cell cycle arrest in the G1 phase and upregulated the cyclin-dependent kinase inhibitor p27KIPI protein in the HeLa cells. Moreover DMMP was able to induce marked nuclear apoptotic morphology in HeLa cells. DMMP induced apoptosis and loss of mitochondrial membrane potential (ΔΨm) in the HeLa cells. Although the activated forms of caspase-9 and -3 in HeLa cells were detected, pretreatment with caspase inhibitors (Ac-DEVD-CHO and Z-VAD-FMK) failed to attenuate DMMP-induced cell death. In addition, protein levels of the p53 family members, p53 and p73, were upregulated, and DMMP significantly increased the mRNA expression of pro-apoptotic Bcl-2 family genes (PUMA, NOXA, Bax, Bad and Bim). HPV E6-E7 mRNA levels were reduced. In conclusion, DMMP demonstrates potential for use in the treatment of cervical cancer.

View Figures

View References

1	Koehn FE and Carter GT: The evolving role of natural products in drug discovery. Nat Rev Drug Discov. 4:206–220. 2005. View Article : Google Scholar : PubMed/NCBI
2	Miller KI, Qing C, Sze DM and Neilan BA: Investigation of the biosynthetic potential of endophytes in traditional Chinese anticancer herbs. PLoS One. 7:e359532012. View Article : Google Scholar : PubMed/NCBI
3	Tan RX and Zou WX: Endophytes: a rich source of functional metabolites. Nat Prod Rep. 18:448–459. 2001.PubMed/NCBI
4	Reed JC: Drug insight: cancer therapy strategies based on restoration of endogenous cell death mechanisms. Nat Clin Pract Oncol. 3:388–398. 2006. View Article : Google Scholar : PubMed/NCBI
5	Frankfurt OS and Krishan A: Apoptosis-based drug screening and detection of selective toxicity to cancer cells. Anticancer Drugs. 14:555–561. 2003. View Article : Google Scholar : PubMed/NCBI
6	Chen F, Wang W and El-Deiry WS: Current strategies to target p53 in cancer. Biochem Pharmacol. 80:724–730. 2010. View Article : Google Scholar : PubMed/NCBI
7	Collavin L, Lunardi A and Del Sal G: p53-family proteins and their regulators: hubs and spokes in tumor suppression. Cell Death Differ. 17:901–911. 2010. View Article : Google Scholar : PubMed/NCBI
8	Ferreira CG, Tolis C and Giaccone G: p53 and chemosensitivity. Ann Oncol. 10:1011–1021. 1999. View Article : Google Scholar : PubMed/NCBI
9	Lunghi P, Costanzo A, Mazzera L, Rizzoli V, Levrero M and Bonati A: The p53 family protein p73 provides new insights into cancer chemosensitivity and targeting. Clin Cancer Res. 15:6495–6502. 2009. View Article : Google Scholar : PubMed/NCBI
10	Bisso A, Collavin L and Del Sal G: p73 as a pharmaceutical target for cancer therapy. Curr Pharm Des. 17:578–590. 2011. View Article : Google Scholar : PubMed/NCBI
11	Slade N and Horvat A: Targeting p73 - a potential approach in cancer treatment. Curr Pharm Des. 17:591–602. 2011. View Article : Google Scholar : PubMed/NCBI
12	Lain S, Hollick JJ, Campbell J, et al: Discovery, in vivo activity, and mechanism of action of a small-molecule p53 activator. Cancer Cell. 13:454–463. 2008. View Article : Google Scholar : PubMed/NCBI
13	Vassilev LT, Vu BT, Graves B, et al: In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science. 303:844–848. 2004. View Article : Google Scholar : PubMed/NCBI
14	Peirce SK and Findley HW: The MDM2 antagonist nutlin-3 sensitizes p53-null neuroblastoma cells to doxorubicin via E2F1 and TAp73. Int J Oncol. 34:1395–1402. 2009.PubMed/NCBI
15	Sampath D, Calin GA, Puduvalli VK, et al: Specific activation of microRNA106b enables the p73 apoptotic response in chronic lymphocytic leukemia by targeting the ubiquitin ligase Itch for degradation. Blood. 113:3744–3753. 2009. View Article : Google Scholar : PubMed/NCBI
16	Phuwapraisirisan P, Rangsan J, Siripong P and Tip-Pyang S: New antitumour fungal metabolites from Alternaria porri. Nat Prod Res. 23:1063–1071. 2009. View Article : Google Scholar : PubMed/NCBI
17	Suemitsu R, Ohnishi K, Morikawa Y and Nagatomo S: Zinnimidine and 5-(3′,3′-dimethylallyloxy)-7-methoxy-6-methylphthalide from Alternaria porri. Phytochemistry. 38:495–497. 1995.PubMed/NCBI
18	Yang XL, Zhang S, Hu QB, Luo DQ and Zhang Y: Phthalide derivatives with antifungal activities against the plant pathogens isolated from the liquid culture of Pestalotiopsis photiniae. J Antibiot (Tokyo). 64:723–727. 2011. View Article : Google Scholar : PubMed/NCBI
19	Malumbres M and Barbacid M: To cycle or not to cycle: a critical decision in cancer. Nat Rev Cancer. 1:222–231. 2001. View Article : Google Scholar : PubMed/NCBI
20	Hengst L and Reed SI: Translational control of p27^KIP1 accumulation during the cell cycle. Science. 271:1861–1864. 1996. View Article : Google Scholar
21	Pagano M, Tam SW, Theodoras AM, et al: Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science. 269:682–685. 1995. View Article : Google Scholar : PubMed/NCBI
22	Vervoorts J and Lüscher B: Post-translational regulation of the tumor suppressor p27(KIP1). Cell Mol Life Sci. 65:3255–3264. 2008. View Article : Google Scholar : PubMed/NCBI
23	Harbour JW and Dean DC: The Rb/E2F pathway: expanding roles and emerging paradigms. Genes Dev. 14:2393–2409. 2000. View Article : Google Scholar : PubMed/NCBI
24	Danial NN and Korsmeyer SJ: Cell death: critical control points. Cell. 116:205–219. 2004. View Article : Google Scholar : PubMed/NCBI
25	Chipuk JE and Green DR: How do BCL-2 proteins induce mitochondrial outer membrane permeabilization? Trends Cell Biol. 18:157–164. 2008. View Article : Google Scholar : PubMed/NCBI
26	Ashkenazi A and Dixit VM: Death receptors: signaling and modulation. Science. 281:1305–1308. 1998. View Article : Google Scholar : PubMed/NCBI
27	Chipuk JE and Green DR: Do inducers of apoptosis trigger caspase-independent cell death? Nat Rev Mol Cell Biol. 6:268–275. 2005. View Article : Google Scholar : PubMed/NCBI
28	Brooks CL and Gu W: p53 ubiquitination: Mdm2 and beyond. Mol Cell. 21:307–315. 2006. View Article : Google Scholar : PubMed/NCBI
29	Sullivan KD, Gallant-Behm CL, Henry RE, Fraikin JL and Espinosa JM: The p53 circuit board. Biochim Biophys Acta. 1825:229–244. 2012.PubMed/NCBI
30	Diaz D, Santander MA and Chavez JA: HPV-16 E6 and E7 oncogene expression is downregulated as a result of Mdm2 knockdown. Int J Oncol. 41:141–146. 2012.
31	Chipuk JE and Green DR: Dissecting p53-dependent apoptosis. Cell Death Differ. 13:994–1002. 2006. View Article : Google Scholar : PubMed/NCBI
32	Hemann MT and Lowe SW: The p53-Bcl-2 connection. Cell Death Differ. 13:1256–1259. 2006. View Article : Google Scholar : PubMed/NCBI
33	Villunger A, Michalak EM, Coultas L, et al: p53- and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa. Science. 302:1036–1038. 2003. View Article : Google Scholar : PubMed/NCBI
34	Wu Z, Zheng S and Yu Q: The E2F family and the role of E2F1 in apoptosis. Int J Biochem Cell Biol. 41:2389–2397. 2009. View Article : Google Scholar : PubMed/NCBI
35	Stiewe T and Pützer BM: Role of the p53-homologue p73 in E2F1-induced apoptosis. Nat Genet. 26:464–469. 2000. View Article : Google Scholar : PubMed/NCBI
36	Mebratu Y and Tesfaigzi Y: How ERK1/2 activation controls cell proliferation and cell death: is subcellular localization the answer? Cell Cycle. 8:1168–1175. 2009. View Article : Google Scholar : PubMed/NCBI
37	Amin AR, Paul RK, Thakur VS and Agarwal ML: A novel role for p73 in the regulation of Akt-Foxo1a-Bim signaling and apoptosis induced by the plant lectin, Concanavalin A. Cancer Res. 67:5617–5621. 2007. View Article : Google Scholar : PubMed/NCBI